Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B N Cronstein

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Annals of the Rheumatic Diseases|October 14, 2004
Pharmacogenetics in the rheumatic diseasesB N Cronstein
Rheumatic Diseases Clinics of North America|November 15, 1997
The mechanism of action of methotrexateB N Cronstein
The Mount Sinai Journal of Medicine, New York|May 1, 1993
The pharmacology of antiinflammatory agents: a new paradigmB N Cronstein
Inflammation|October 1, 1992
Molecular mechanism of methotrexate action in inflammationB N Cronstein
The Journal of Laboratory and Clinical Medicine|January 1, 1991
Oxidative insults: sublethal injury to the endothelium by H2O2B N Cronstein
Arthritis and Rheumatism|December 1, 1996
Molecular therapeutics. Methotrexate and its mechanism of actionB N Cronstein
Current Rheumatology Reports|December 21, 2000
Millenial rheumatologyB N Cronstein
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1994
Adenosine, an endogenous anti-inflammatory agentB N Cronstein
Annals of the Rheumatic Diseases|March 15, 2006
Going with the flow: methotrexate, adenosine, and blood flowB N Cronstein
Current Opinion in Rheumatology|May 1, 1994
Adhesion molecules in the pathogenesis of rheumatoid arthritisB N Cronstein
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Annals of the Rheumatic Diseases|October 14, 2004
Pharmacogenetics in the rheumatic diseasesB N Cronstein
Rheumatic Diseases Clinics of North America|November 15, 1997
The mechanism of action of methotrexateB N Cronstein
The Mount Sinai Journal of Medicine, New York|May 1, 1993
The pharmacology of antiinflammatory agents: a new paradigmB N Cronstein
Inflammation|October 1, 1992
Molecular mechanism of methotrexate action in inflammationB N Cronstein
The Journal of Laboratory and Clinical Medicine|January 1, 1991
Oxidative insults: sublethal injury to the endothelium by H2O2B N Cronstein
Arthritis and Rheumatism|December 1, 1996
Molecular therapeutics. Methotrexate and its mechanism of actionB N Cronstein
Current Rheumatology Reports|December 21, 2000
Millenial rheumatologyB N Cronstein
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1994
Adenosine, an endogenous anti-inflammatory agentB N Cronstein
Annals of the Rheumatic Diseases|March 15, 2006
Going with the flow: methotrexate, adenosine, and blood flowB N Cronstein
Current Opinion in Rheumatology|May 1, 1994
Adhesion molecules in the pathogenesis of rheumatoid arthritisB N Cronstein
Pageof 7